Search results
Author(s):
Tasneem Z Naqvi
Added:
3 years ago
Congestive heart failure (CHF) is the number one hospital discharge diagnosis for older adults and the leading cause of hospital readmissions, reflecting poor quality of life for patients and increased healthcare resource use, and is the cause of 300,000 deaths annually.1 Cardiac resynchronization therapy (CRT) has become a new effective treatment modality in those with drug-resistant advanced…
View more
The Evolution of Lead Extraction
Author(s):
Melanie Maytin
,
Laurence M Epstein
Added:
3 years ago
Article
Author(s):
Malcolm M Bersohn
Added:
3 years ago
Permanent pacemakers have been used to treat patients with symptomatic bradycardia for 45 years. The earliest pacemakers paced only the ventricle and were used primarily for patients with complete heart block. The need for atrial pacing became apparent as pacing for sinus node dysfunction became more common. Initially, only single-chamber pacing was possible in the atrium, and this was a good…
View more
Author(s):
Kendra J Grubb
Added:
1 year ago
Dr Kendra Grubb (Emory Structural Heart and Valve Center, GA, US) outlines the interim analysis of the Optimize PRO Study (NCT04091048), originally presented at EuroPCR 2022.
Optimize PRO aimed to evaluate valve performance and procedural outcomes of optimised TAVR care using Medtronic's Evolut™ PRO and Evolut™ PRO+ devices.
Findings are promising and show that no patients experienced a…
View more
Author(s):
Malcolm M Bersohn
Added:
3 years ago
Permanent pacemakers have been used to treat patients with symptomatic bradycardia for 45 years. The earliest pacemakers paced only the ventricle and were used primarily for patients with complete heart block. The need for atrial pacing became apparent as pacing for sinus node dysfunction became more common. Initially, only single-chamber pacing was possible in the atrium, and this was a good…
View more
Author(s):
Somsupha Kanjanauthai
,
Kabir Bhasin
,
Luigi Pirelli
,
et al
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) has been established as a therapeutic option for patients with severe symptomatic aortic stenosis who are considered to be of intermediate, high or prohibitive surgical risk.1–5 As a result of favorable TAVR outcomes and substantial improvements in transcatheter heart valve (THV) technologies and implantation techniques, the feasibility of broadening…
View more
Author(s):
Michael R Rosen
Added:
3 years ago
Cardiac arrhythmia diagnosis is as old as the Bible and ancient Chinese literature.1 Treatment has progressed from the natural products used by the ancients, to formalized attempts at pharmacological therapy over the last 300 years (with digitalis and cinchona bark being the lead compounds), to the modern use of devices and ablation. However, with the exception of electronic pacing for…
View more
Jitendra Singh Makkar
Job title: Director of Cardiology
Author
Harry Mond
Job title: Associate Professor
Author
Vivek Reddy
Job title: Director of Cardiac Arrhythmia Services
Author